Stephany Verstraete - 30 Aug 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF MARKETING OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
30 Aug 2024
Net transactions value
-$14,923
Form type
4
Filing time
04 Sep 2024, 16:12:24 UTC
Previous filing
08 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1,109 +2.5% 46,267 30 Aug 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1,404 +3% 47,671 30 Aug 2024 Direct F2
transaction TDOC Common Stock Options Exercise +3,255 +6.8% 50,926 30 Aug 2024 Direct F2
transaction TDOC Common Stock Sale $14,923 -2,083 -4.1% $7.16 48,843 03 Sep 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Options Exercise $0 -1,109 -14% $0.000000 6,658 30 Aug 2024 Common Stock 1,109 Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -1,404 -33% $0.000000 2,808 30 Aug 2024 Common Stock 1,404 Direct F2, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -3,255 -14% $0.000000 19,532 30 Aug 2024 Common Stock 3,255 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.